Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Mach7 Technologies Ltd. ( (AU:M7T) ) has issued an announcement.
Mach7 Technologies Limited announced that it will release its Q2 FY25 results on 31 January 2025. Following the release, CEO Mike Lampron and CFO Dyan O’Herne will host a webinar for investors, allowing for engagement and Q&A. This announcement underlines Mach7’s commitment to transparency and stakeholder engagement, potentially impacting investor relations positively.
More about Mach7 Technologies Ltd.
Mach7 Technologies, founded in 2007, is a medical imaging systems provider offering innovative image management and viewing solutions for healthcare organizations. Their core offering, the Mach7 Enterprise Imaging Solution, includes Enterprise Data Management and Enterprise Diagnostic Viewing applications, providing fast storage, access, retrieval, and viewing of images across healthcare networks. The company’s solutions can be deployed on a component basis or as a comprehensive platform, serving over 165 customers in 15 countries, ranging from large health systems to independent provider groups.
YTD Price Performance: 0%
Average Trading Volume: 4,072
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $51.67M
For detailed information about M7T stock, go to TipRanks’ Stock Analysis page.
